Pharmaceutical

Filter

Current filters:

None

Popular Filters

65 to 89 of 7014 results

Asia Healthcare Forum identifies challenges ahead for meetings in the sector

Asia Healthcare Forum identifies challenges ahead for meetings in the sector

13-08-2014

The inaugural Healthcare Meetings Forum Asia was over-subscribed on August 1 at Suntec Singapore, an…

Asia-PacificMarkets & MarketingPharmaceuticalRegulationSingapore

Kadcyla’s rejection confirms that NICE must change the way it considers cancer treatment, says analyst

Kadcyla’s rejection confirms that NICE must change the way it considers cancer treatment, says analyst

13-08-2014

“The National Institute for Health and Care Excellence’s recent rejection of Kadcyla, Roche’s latest…

KadcylaOncologyPharmaceuticalPricingRegulationRocheUK

Strong growth forecast for Saudi Arabia pharmaceuticals market

Strong growth forecast for Saudi Arabia pharmaceuticals market

13-08-2014

Pharmaceuticals products sales in Saudi Arabia are expected to exceed a value of $ 7 billion by 2018,…

Business FinanceFinancialMarkets & MarketingPharmaceuticalProductionRest of the WorldSaudi Arabia

Boehringer Ingelheim acquires licensing rights for Artilysin technology

Boehringer Ingelheim acquires licensing rights for Artilysin technology

13-08-2014

Artilysin, a new and innovative technological approach in the fight against pathogenic and multi-resistant…

Antibiotics and Infectious diseasesArtilysinBoehringer IngelheimGermanyLicensingLysando AGPharmaceutical

ALK Abello reports strong improvement in 2nd-qtr financials

ALK Abello reports strong improvement in 2nd-qtr financials

13-08-2014

Denmark-based allergy specialist ALK Abello has reported significant progress in its sales for the second…

ALK AbelloDenmarkFinanceFinancialNorwegian kronePharmaceuticalRespiratory and Pulmonary

Insys submits Dronabinol oral solution New Drug Application

Insys submits Dronabinol oral solution New Drug Application

13-08-2014

Supportive care specialist Insys Therapeutics has made a New Drug Application submission to the US Food…

CannabinoidsDronabinolEntheogensGastro-intestinalsInsys TherapeuticsPharmaceuticalRegulationTetrahydrocannabinolUSA

AstraZeneca reports positive results from lesinurad trial for gout

AstraZeneca reports positive results from lesinurad trial for gout

13-08-2014

Anglo-Swedish drug major AstraZeneca has said its Phase III trials of lesinurad in combination with xanthine…

AstraZenecaEuropeGastro-intestinalslesinuradPharmaceuticalResearchSymptomatic gout

Medicines New Zealand updates its code of practice to cover social media

Medicines New Zealand updates its code of practice to cover social media

13-08-2014

New Zealand's pharmaceutical industry association, Medicines New Zealand, has updated its Code of Practice…

New ZealandPharmaceuticalPharmaceuticals policyPharmacologyRegulation

Merck KGaA 2nd-qtr earnings beat expectations

Merck KGaA 2nd-qtr earnings beat expectations

13-08-2014

German pharmaceuticals and chemicals major Merck KGaA said this morning that it has generated organic…

Business FinanceFinancialGermanyMerck KGaAMerck SeronoPharmaceutical

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

12-08-2014

German family-owned pharma major Boehringer Ingelheim reported first-half 2014 results, showing that…

Boehringer IngelheimChronic obstructive pulmonary disease therapyFinancialGermanyPharmaceutical

Intercept shares rocket on positive liver drug results

Intercept shares rocket on positive liver drug results

12-08-2014

Shares of US drug developer Intercept Pharmaceuticals leapt 53% to $358.07 in after-hours trading on…

Intercept PharmaceuticalsLiver diseaseNephrology and Hepatologyobeticholic acidPharmaceuticalResearchUSA

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

12-08-2014

Dutch biotech company Prosensa will receive a 5 million euros ($7 million) funding boost from US non-profit…

Duchenne Muscular DystrophyFinancialNetherlandsPharmaceuticalProsensaRare diseasesResearchUSA

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

12-08-2014

Global pharma, medical and biotechnology (PMB) M&A activity during the first half of 2014 hit the highest…

Business FinanceGlobalMergers & AcquisitionsPharmaceutical

OPKO’s Rayaldee Ph III trial meets primary endpoints in SHPT

12-08-2014

US drugmaker OPKO Health has released positive top-line results from the first pivotal Phase III trial…

Endocrine systemJoel MelnickNephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeResearchUSAVitamin D

Synta appoints Sanofi's Anne Whitaker as chief executive

Synta appoints Sanofi's Anne Whitaker as chief executive

12-08-2014

Coming from her position as president of Sanofi’s North American pharma division, Anne Whitaker has…

Anne WhitakerBoardroomBreast cancerElesclomolOncologyPharmaceuticalSafi R. BahcallSanofiSynta PharmaceuticalsUSA

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

11-08-2014

French pharma major Sanofi has entered into a worldwide exclusive licensing agreement with the USA’s…

AfrezzaDiabetesGlobalInsulin therapyLicensingMannKindPeptide hormonesPharmaceuticalSanofi

Positive new Ph III data with Novo Nordisk’s Xultophy

Positive new Ph III data with Novo Nordisk’s Xultophy

11-08-2014

Positive new pivotal Phase III data about Xultophy (insulin degludec/liraglutide), formerly known as…

DiabetesIDegLiraNovo NordiskPharmaceuticalResearchXultophy

Ukraine may face drugs shortage this year

Ukraine may face drugs shortage this year

11-08-2014

Ukraine plans to ban pharmaceutical imports from Russia, except 20 vital drugs, the analogues of which…

Markets & MarketingPharmaceuticalPoliticsPricingRussiaUkraine

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

11-08-2014

The treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through…

BayerGleevecGlivecMarkets & MarketingNovartisOncologyPfizerPharmaceuticalStivargaSutent

Russia may restrict drug imports from Western countries

Russia may restrict drug imports from Western countries

11-08-2014

The Russian Federation Council, the upper house of the Federal Assembly of the country, has put forward…

Drug safetyHealthcareMarkets & MarketingPharmaceuticalPoliticsRussia

65 to 89 of 7014 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top